• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态影像学方法在识别侵袭性肝细胞癌中的应用。

Multimodality imaging approach in identifying invasive hepatocellular carcinoma.

机构信息

Department of Radiology, University of Texas Medical Branch, Galveston, TX 77555, United States of America.

Department of Radiology, University of Texas Medical Branch, Galveston, TX 77555, United States of America.

出版信息

Clin Imaging. 2023 May;97:34-43. doi: 10.1016/j.clinimag.2023.03.002. Epub 2023 Mar 4.

DOI:10.1016/j.clinimag.2023.03.002
PMID:36889113
Abstract

Hepatocellular carcinoma (HCC) is the 5th most common neoplasm and the 3rd leading cause of cancer related mortality worldwide. Early stages of the neoplasm may be treated curatively with liver resection or orthotopic liver transplant. However, HCC has a high propensity for vascular and locoregional invasion, which can preclude these treatment options. The portal vein is the most invaded structure, while other regional structures affected include the hepatic vein, inferior vena cava, gallbladder, peritoneum, diaphragm, and the gastrointestinal tract. Management of invasive and advanced stages of HCC includes modalities such as transarterial chemoembolization (TACE), transarterial radioembolization (TARE), and systemic chemotherapy, which are non-curative and focus on relieving tumor burden and slowing progression. A multimodality imaging approach is effective in identifying areas of tumor invasion and distinguishing between bland and tumor thrombi. Due to implications in prognosis and management, it is imperative for radiologists to accurately identify imaging patterns of regional invasion by HCC and to distinguish between bland and tumor thrombus in cases of potential vascular invasion.

摘要

肝细胞癌 (HCC) 是全球第 5 常见的肿瘤,也是第 3 大癌症相关死亡原因。肿瘤的早期阶段可以通过肝切除术或原位肝移植进行治愈性治疗。然而,HCC 具有很高的血管和局部侵袭性,这可能会排除这些治疗选择。门静脉是最常被侵犯的结构,而受影响的其他区域结构包括肝静脉、下腔静脉、胆囊、腹膜、膈肌和胃肠道。侵袭性和晚期 HCC 的治疗方法包括经动脉化疗栓塞 (TACE)、经动脉放射栓塞 (TARE) 和全身化疗等方法,这些方法是非治愈性的,主要侧重于减轻肿瘤负担和减缓进展。多模态成像方法可有效识别肿瘤侵犯区域,并区分良性和肿瘤血栓。由于对预后和管理的影响,放射科医生必须准确识别 HCC 的区域侵犯的影像学模式,并在存在潜在血管侵犯的情况下区分良性和肿瘤血栓。

相似文献

1
Multimodality imaging approach in identifying invasive hepatocellular carcinoma.多模态影像学方法在识别侵袭性肝细胞癌中的应用。
Clin Imaging. 2023 May;97:34-43. doi: 10.1016/j.clinimag.2023.03.002. Epub 2023 Mar 4.
2
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.开发一种预后评分,以预测伴有门静脉侵犯的肝细胞癌对钇-90 放射性栓塞治疗的反应。
J Hepatol. 2018 Apr;68(4):724-732. doi: 10.1016/j.jhep.2017.12.026. Epub 2018 Jan 10.
3
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.联合化疗栓塞和放疗与单纯化疗栓塞治疗侵犯肝静脉或下腔静脉的肝细胞癌。
Cardiovasc Intervent Radiol. 2021 Jul;44(7):1060-1069. doi: 10.1007/s00270-021-02815-3. Epub 2021 Mar 21.
4
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.经动脉化疗栓塞术联合仑伐替尼对比经动脉化疗栓塞术联合索拉非尼作为伴门静脉癌栓的肝细胞癌一线治疗的前瞻性随机研究。
Cancer. 2021 Oct 15;127(20):3782-3793. doi: 10.1002/cncr.33677. Epub 2021 Jul 8.
5
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.肝细胞癌经动脉化疗栓塞与经动脉放射性栓塞治疗:治疗方式选择的优化
Hepatol Int. 2016 Nov;10(6):883-892. doi: 10.1007/s12072-016-9722-9. Epub 2016 Apr 28.
6
Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study.经动脉化疗栓塞与最佳支持治疗对伴有门静脉癌栓的肝细胞癌患者的疗效比较:一项多中心研究。
Eur J Surg Oncol. 2019 Aug;45(8):1460-1467. doi: 10.1016/j.ejso.2019.03.042. Epub 2019 Apr 12.
7
Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.经动脉放射性栓塞联合化疗栓塞治疗双叶肝细胞癌的安全性和有效性:一项单中心回顾性研究
Cardiovasc Intervent Radiol. 2018 Mar;41(3):459-465. doi: 10.1007/s00270-017-1826-7. Epub 2017 Oct 24.
8
Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.术前化疗栓塞术治疗可切除的伴门静脉侵犯肝细胞癌的疗效与安全性:一项前瞻性对照研究
Eur Radiol. 2016 Jul;26(7):2078-88. doi: 10.1007/s00330-015-4021-8. Epub 2015 Sep 22.
9
Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report.两名患者均患有巨大肝细胞癌和门静脉侵犯,在两次转换后接受肝移植:病例报告。
World J Gastroenterol. 2024 Sep 28;30(36):4071-4077. doi: 10.3748/wjg.v30.i36.4071.
10
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.经动脉化疗栓塞术和(90)钇放射性栓塞术治疗肝细胞癌:超越中期疾病的当前应用综述。
AJR Am J Roentgenol. 2015 Oct;205(4):742-52. doi: 10.2214/AJR.15.14802.

引用本文的文献

1
Hepatocellular Carcinoma (HCC) Metastasis to the Diaphragm Muscle: A Systematic Review and Meta-Analysis of Case Reports.肝细胞癌转移至膈肌:病例报告的系统评价与荟萃分析
Cancers (Basel). 2024 Sep 4;16(17):3076. doi: 10.3390/cancers16173076.